Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,830 | -31,341 | -30,326 | -15,388 | -79,129 |
| Depreciation Amortization | 14,247 | 9,312 | 5,722 | 2,724 | 11,287 |
| Accounts receivable | -30,494 | -32,554 | -24,834 | -12,997 | -16,892 |
| Other Working Capital | -49,850 | -26,343 | -6,494 | -10,371 | -56,015 |
| Other Operating Activity | 63,991 | 55,100 | 39,928 | 20,651 | 51,663 |
| Operating Cash Flow | $-69,936 | $-25,826 | $-16,004 | $-15,381 | $-89,086 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 95,120 | 94,268 | 85,408 | -17,621 | 65,722 |
| PPE Investments | -97,318 | -75,002 | -52,671 | -21,917 | -34,857 |
| Other Investing Activity | 50 | 50 | 50 | 0 | -50 |
| Investing Cash Flow | $-2,148 | $19,316 | $32,787 | $-39,538 | $30,815 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 23,640 | 5,182 | 5,182 | 5,182 | N/A |
| Debt Repayment | -875 | -773 | N/A | N/A | N/A |
| Common Stock Issued | 8,598 | 4,626 | 1,705 | 1,038 | 7,949 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -200,807 |
| Financing Cash Flow | $31,363 | $9,035 | $6,887 | $6,220 | $-192,858 |
| Beginning Cash Position | 247,796 | 247,796 | 247,796 | 247,796 | 498,925 |
| End Cash Position | 207,075 | 250,321 | 271,466 | 199,097 | 247,796 |
| Net Cash Flow | $-40,721 | $2,525 | $23,670 | $-48,699 | $-251,129 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,936 | -25,826 | -16,004 | -15,381 | -89,086 |
| Capital Expenditure | -97,318 | -75,002 | -52,671 | -21,917 | -34,857 |
| Free Cash Flow | -167,254 | -100,828 | -68,675 | -37,298 | -123,943 |